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A 48-year-old male Caucasian, with no relevant medical history except for a mild depression, was found 
by the partner, passed out on the bedroom floor. Since he was found in cardiac arrest, cardiopulmonary 
resuscitation was attempted, without success.  Initially, it was suspected to be a suicide attempt and 
autopsy findings revealed coronary atherosclerosis of about 40%, with no other recoverable cardiac 
findings.
The brain showed multiple probable neoplastic lesions, associated with cerebral and cerebellar 
hemorrhage. The primary tumor was not identified, but the victim had multiple cutaneous nevi. 
Histological examination revealed melanoma metastases, confirmed by immunohistochemistry.
In this case, the forensic autopsy allowed an accurate determination of the cause of death. Besides having 
fulfilled its role to the judiciary system, the autopsy also had relevance from an epidemiological point of 
view, which is essential for Public Health prevention programs.
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INTRODUCTION
Brain metastases usually occur at advanced stages of cancer. 
However, brain metastases can be the first and only clinical 
manifestation of an unknown tumor.1,2 It is estimated that 
20% to 25% of cancer patients develop brain metastases and 
autopsy studies demonstrate that up to 25% of patients die 
from it.1,3,4 A study shows that 3 to 14% of all intracranial 
metastases will eventually bleed.5
Intracranial metastases can be located in the parenchyma 
(cerebral hemispheres, cerebellum, brainstem) or the 
meninges. Brain metastases are responsible for 2/3 of 
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Some tumors, like melanoma, generally produce multiple 
metastases, while others, like breast carcinoma, arise most 
often with a single lesion.4,6
Malignant melanoma is the third most common cause of 
central nervous system (CNS) metastases, after breast 
and lung cancer, although it has the highest propensity 
to metastasize to that location.7 Unlike lung, kidney and 
breast cancer metastases, that are predominantly solitary, 
the malignant melanoma often metastasizes to multiple 
locations.8
The 5-year cumulative risk for developing melanoma CNS 
metastases is approximately 7 percent.9 In patients with 
malignant melanoma, the intracranial metastases appear 
to occur in 58% of male gender and 42% of female.10 
However, autopsy reports indicate that the incidence of 
brain metastases may be as high as 75% post-mortem, being 
most of them clinically silent.11
Melanoma patients with brain metastases in general have 
a poor prognosis. In a combined analysis of two series 
totaling almost 1400 patients, the median survival was 
four months, and one year survival rates were 9 and 19%, 
respectively.12 In this context, it is relevant to state that 20 
to 54% of melanoma patients die from brain metastases-
related complications.13
CASE REPORT
A 48-year-old male Caucasian, with no relevant medical 
history except for a mild depression, was found by the 
partner, passed out on the bedroom floor. Since he was 
found in cardiac arrest, cardiopulmonary resuscitation was 
attempted, without success.  Initially, it was suspected to be 
a suicide attempt and autopsy findings revealed coronary 
atherosclerosis of about 40%, with no other recoverable 
cardiac findings.
The brain showed multiple probable neoplastic lesions, 
associated with cerebral and cerebellar hemorrhage. (fig. 
1A-D) The primary tumor was not identified, but the victim 
had multiple cutaneous nevi. Histological examination 
revealed melanoma metastases, (fig.2A&B) confirmed by 
immunohistochemistry (fig.3), which led to the conclusion 
that the case was of melanoma metastases.
DISCUSSION
Malignant melanoma is a relatively common, usually 
asymptomatic tumor. Although most melanomas have its 
origin on skin, other places of origin include oral, anal 
and genital mucosa, esophagus, eye and meninges. Like 
other epithelial malignancies of the skin, sunlight may 
play an important role in the development of malignant 
melanoma, but it’s not the only etiological factor. The 
presence of a pre-existing nevus, hereditary factors and 
exposure to carcinogens may trigger disease development.8 
Approximately 80% of brain metastases are located in the 
cerebral hemispheres, 15% in the cerebellum and 5% in 
the brain stem.14 There is an association between the size 
of malignant melanoma brain metastases and the respective 
clinical signs. When symptoms occur, they are nonspecific 
and vary depending on the location of the lesion. Headache 
Figure 2 (A-D): Brain aspect. Observable macroscopic cerebral hemorrhage, which is 
more often related to malignant melanoma metastases than to CNS primary tumors. Note 
the dark coloured nodules at the surface (arrowhead) (A)
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Figure 2A: Proliferation of neoplastic cells, characterized by cells with marked atypia and 
pleomorphism and is richly vascularized. In the center of the field there is a cell containing a small 
amount of melanin pigment. (HE stain; X50) B. Bizarre nuclei, vacuoles, pleomorphic cells, a blood 
vessel in cerebellum ( HE stain; X100).
Figure 3: Immunostaining of neoplastic cells 
was positive for S100 protein (IHC; X400)
Melanoma with brain metastases
is the most common presenting symptom, but patients 
may also present more serious symptoms like seizures, 
hemiplegia or visual compromise, due to raised intracranial 
pressure. These phenomena may suggest large (>4 cm) 
lesions.8
Five to ten percent of brain metastases present acutely 
due to stroke. This may be caused by hemorrhage into a 
metastases, hypercoagulability, invasion or compression of 
an artery by tumor, or embolization of tumor cells.15 Unlike 
most other cancer metastases to the brain, melanoma has 
a high propensity to hemorrhage spontaneously, with rates 
ranging from 8.6 to 24 percent.16 This can be the first and 
only symptom of a metastasized neoplastic disease, as was 
proved to be this case.
CONCLUSION 
In this case, the forensic autopsy allowed an accurate 
determination of the cause of death. Besides having 
fulfilled its role to the judiciary system, the autopsy also had 
relevance from an epidemiological point of view, which is 
essential for Public Health prevention programs.
Currently, given the greater information available on the 
first signs of cutaneous melanoma, many cases can be 
cured surgically. Awareness and screening programs have a 
crucial role in reducing deaths from melanoma.
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